Inventor

Richard B. Sparks

Inventor

Wilmington, DE, US

Overview

1997–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 62 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds39%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%

A61KPreparations for medical, dental or toiletry purposes20%

C07BGeneral methods of organic chemistry2%

C07CAcyclic or carbocyclic compounds2%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%

PatentTitleYear

11,091,491Heterocyclic compounds as PI3K-y inhibitors2021 10,738,057Tertiary alcohols as PI3K-g inhibitors2020 10,653,6771,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase2020 10,646,492Heterocyclylamines as PI3K inhibitors2020 10,618,910Tricyclic heterocycles as BET protein inhibitors2020 10,479,795Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors2019 10,472,368Heterocyclic compounds as PI3K-g inhibitors2019 10,464,947Tricyclic heterocycles as BET protein inhibitors2019 10,376,513Heterocyclylamines as PI3K inhibitors2019 10,369,1371,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase2019 10,259,818Bicyclic azaheterocyclobenzylamines as PI3K inhibitors2019 10,227,359Tricyclic heterocycles as bet protein inhibitors2019 10,138,248Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-g inhibitors2018 10,092,570Heterocyclylamines as PI3K inhibitors2018 10,034,8641,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase2018 9,944,646Bicyclic azaheterocyclobenzylamines as PI3K inhibitors2018 9,938,294Tricyclic heterocycles as BET protein inhibitors2018 9,879,010'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b] pyrimidin-5-yl-amines as Janus kinase inhibitors'2018 9,834,565Tricyclic heterocycles as bet protein inhibitors2017 9,815,839'N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors'2017 9,789,094'1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase'2017 9,730,939'Heterocyclylamines as PI3K inhibitors'2017 9,624,241'Tricyclic heterocycles as BET protein inhibitors'2017 9,580,419'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors'2017 9,527,864'Tricyclic heterocycles as BET protein inhibitors'2016 9,527,848'N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors'2016 9,403,847'Substituted heteroaryl fused derivatives as P13K inhibitors'2016 9,320,732'1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase'2016 9,309,251'Bicyclic azaheterocyclobenzylamines as PI3K inhibitors'2016 9,290,514'Tricyclic heterocycles as BET protein inhibitors'2016 9,227,985'Tricyclic heterocycles as bet protein inhibitors'2016 9,193,721'Fused derivatives as PI3KÎ´ inhibitors'2015 9,096,600'N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors'2015 9,090,611'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors'2015 8,993,605'1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase'2015 8,951,536'N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase'2015 8,871,753'Macrocyclic compounds and their use as kinase inhibitors'2014 8,835,423'Azepine inhibitors of janus kinases'2014 8,822,511'1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase'2014 8,796,319'1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase'2014 8,765,727'Macrocyclic compounds and their use as kinase inhibitors'2014 8,759,359'Substituted heteroaryl fused derivatives as PI3K inhibitors'2014 8,741,895'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors'2014 8,563,541'Azepine inhibitors of Janus kinases'2013 8,507,541'N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase'2013 8,450,351'N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase'2013 8,445,488'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors'2013 8,377,976'N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase'2013 8,088,803'1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase'2012 8,053,433'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors'2011 7,335,667'Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors'2008 7,141,596'Inhibitors of proteins that bind phosphorylated molecules'2006 6,737,424'Alpha-substituted pyridazino quinoline compounds'2004 6,232,313'Pyridazino quinoline compounds'2001 6,214,826'Pyridazino quinoline compounds'2001 6,103,721'Heteroaryl-substituted pyridazino quinoline compounds'2000 5,837,705'Alpha-substituted pyridazino quinoline compounds'1998 5,744,471'Pyridazion quinoline compounds'1998 5,739,133'Pyridazinedione compounds useful in treating neurological disorders'1998 5,733,910'Pyridazinedione compounds useful in the treating neurological disorders'1998 5,604,227'Pyridazinedione compounds useful in treating neurological disorders'1997 5,599,814'Pyridazinedione compounds useful in treating neurological disorders'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2004Based in Linwood, PA, US· patent location history

1998–2004Patents assigned to ZENECA LTD (7)· patent assignee history

2001–2014Based in Boothwyn, PA, US· patent location history

2006–2021Patents assigned to INCYTE CORP (52)· patent assignee history

2012–2015Patents assigned to SPARKS RICHARD B (12)· patent assignee history

2012–2015Patents assigned to COMBS ANDREW P (10)· patent assignee history

2013–2020Based in Wilmington, DE, US· patent location history

2015–2020Patents assigned to INCYTE HOLDINGS CORP (23)· patent assignee history

2019–2021Based in Hockessin, DE, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
INCYTE CORP	52	2006–2021
INCYTE HOLDINGS CORP	23	2015–2020
SPARKS RICHARD Bself	12	2012–2015
COMBS ANDREW P	10	2012–2015
ZENECA LTD	7	1998–2004

Locations

Location	Patents	Span
Wilmington, Delaware, US	38	2013–2020
Boothwyn, Pennsylvania, US	13	2001–2014
Linwood, Pennsylvania, US	9	1997–2004
Hockessin, Delaware, US	2	2019–2021